IM Cannabis Corp (IMCC)
NASDAQ:IMCC
Want to see IMCC full AI Analyst Report?
IMCC Stock Chart & Stats
$1.44
-$0.13(-4.96%)
At close: 4:00 PM EST
$1.44
-$0.13(-4.96%)
Day’s Range― - ―
52-Week Range$0.12 - $3.75
Previous Close$2.49
Volume28.72K
Average Volume (3M)72.27K
Market Cap
$878.11K
Enterprise Value$32.03M
Total Cash (Recent Filing)$1.15M
Total Debt (Recent Filing)$14.95M
Price to Earnings (P/E)―
Beta1.36
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-282.07
Shares Outstanding6,223,323
10 Day Avg. Volume74,089
30 Day Avg. Volume72,265
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.94
Price to Sales (P/S)0.01
P/FCF Ratio0.17
Enterprise Value/Market Cap36.47
Enterprise Value/Revenue0.73
Enterprise Value/Gross Profit4.42
Enterprise Value/Ebitda-6.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.32
Revenue Forecast (FY)$62.75M
Bulls Say, Bears Say
Bulls Say
Germany Growth & EU-GMPRapid German revenue expansion and an EU-GMP-certified platform create a durable competitive advantage in regulated EU markets. Scale in Germany drives revenue concentration, distribution relationships and operational know-how that support longer-term market access and margin improvement versus smaller peers.
2025 Cash-Flow TurnaroundA positive operating cash flow in 2025 demonstrates IM Cannabis can generate real cash when scale and cost discipline align. This evidence of operational cash-generation potential supports the idea management can sustain funding and invest selectively if revenue and margin momentum in core markets persist.
Debt Reduction Via Asset SaleA planned sale that would transfer about C$10.5M of liabilities is a structural deleveraging step. If completed, it materially reduces leverage and lets management reallocate capital to core Israeli operations, improving balance-sheet flexibility and reducing financing pressure over the medium term.
Bears Say
Balance Sheet StrainNegative shareholder equity and roughly $15M of debt materially weaken financial flexibility and distort leverage ratios. This reduces capacity to absorb shocks, constrains access to traditional financing, elevates restructuring risk and raises the probability of dilutive financing or asset sales to shore up capital.
Return To Cash BurnA reversion to negative operating and free cash flow erodes runway and forces reliance on external funding. Inconsistent cash generation increases dilution risk, limits the ability to invest in growth or margin expansion, and makes long-term planning and creditor negotiations more difficult.
Related-Party Transaction RiskA proposed sale to a CEO-controlled buyer creates governance and minority-holder risks. Related-party deals can face additional regulatory scrutiny and conflicts, potentially delaying deleveraging or producing terms unfavorable to outsiders, which undermines confidence in capital allocation outcomes.
IM Cannabis Corp News
IMCC FAQ
What was IM Cannabis Corp’s price range in the past 12 months?
IM Cannabis Corp lowest stock price was $0.12 and its highest was $3.75 in the past 12 months.
What is IM Cannabis Corp’s market cap?
IM Cannabis Corp’s market cap is $878.11K.
When is IM Cannabis Corp’s upcoming earnings report date?
IM Cannabis Corp’s upcoming earnings report date is Aug 17, 2026 which is in 52 days.
How were IM Cannabis Corp’s earnings last quarter?
IM Cannabis Corp released its earnings results on May 13, 2026. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.28.
Is IM Cannabis Corp overvalued?
According to Wall Street analysts IM Cannabis Corp’s price is currently Overvalued.
Does IM Cannabis Corp pay dividends?
IM Cannabis Corp does not currently pay dividends.
What is IM Cannabis Corp’s EPS estimate?
IM Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IM Cannabis Corp have?
IM Cannabis Corp has 6,223,323 shares outstanding.
What happened to IM Cannabis Corp’s price movement after its last earnings report?
IM Cannabis Corp reported an EPS of -$0.28 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.187%.
Which hedge fund is a major shareholder of IM Cannabis Corp?
Currently, no hedge funds are holding shares in IMCC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IM Cannabis Corp
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
Technical Analysis
Ownership Overview
23.24% Insiders
0.23% Other Institutional Investors
76.53% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---